First Interchangeable Humira Biosimilar Approved In US
Boehringer Ingelheim’s Cyltezo Adalimumab Rival Is Granted Second Ever FDA Designation
• By David Wallace
Boehringer Ingelheim’s Cyltezo Is The First Approved Interchangeable Humira Biosimilar • Source: Alamy 
